• Citer

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

par Metzger-Filho, Otto;de Azambuja, Evandro ;Procter, Marion;Krieguer, Magalie;Smith, Ian;Baselga, José;Cameron, David;Untch, Michael;Jackisch, Christian;Bell, Richard;Gianni, Luca;Goldhirsch, Aron;Piccart-Gebhart, Martine ;Gelber, Richard
Référence Breast cancer research and treatment, 155, 1, page (127-132)
Publication Publié, 2016-01

Article révisé par les pairs

• Détails
• Contenu

Titre:	Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Auteur:	Metzger-Filho, Otto; de Azambuja, Evandro; Procter, Marion; Krieguer, Magalie; Smith, Ian; Baselga, José; Cameron, David; Untch, Michael; Jackisch, Christian; Bell, Richard; Gianni, Luca; Goldhirsch, Aron; Piccart-Gebhart, Martine; Gelber, Richard
Informations sur la publication:	Breast cancer research and treatment, 155, 1, page (127-132)
Statut de publication:	Publié, 2016-01
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	Disease-free survival
	HER2+
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-015-3656-0
	info:scp/84953357758